Showing 1 - 10 of 25
A model of patent dispute resolution, which alsoconsiders early stage patent and development investments by both the patentowner and the possible defendant, is presented. The model is comprised of three stages involving an investment firm and aninfringing firm. The three stages of the model are...
Persistent link: https://www.econbiz.de/10014201650
Persistent link: https://www.econbiz.de/10001074102
Persistent link: https://www.econbiz.de/10001140987
Persistent link: https://www.econbiz.de/10003932264
Persistent link: https://www.econbiz.de/10001185803
Persistent link: https://www.econbiz.de/10001155712
Persistent link: https://www.econbiz.de/10001167673
This paper estimates the total cost of patent litigation to alleged infringers. We use a large sample of stock market event studies around the date of lawsuit filings for US public firms from 1984-99. We find that the total costs of litigation are much greater than legal fees and costs are large...
Persistent link: https://www.econbiz.de/10014050928
Pharmacogenomics promises to revolutionize medicine by using genetic information to guide drug therapy. Genetic tests will help doctors improve drug safety and efficacy by better matching patients and drugs. This Article evaluates the effectiveness of patent-based incentives to create genetic...
Persistent link: https://www.econbiz.de/10014085303
We provide empirical evidence that many multi-product firms have each participated in several cartels over the past 50 years. Standard analysis of cartel conduct, as well as enforcement policy, is rooted in the presumption that each cartel in which a given firm participates is a singular...
Persistent link: https://www.econbiz.de/10014112002